Please follow this link to the publication.

Prof.Dr. Nicolas van Mieghem, Erasmus Medical Center Brief Summary: The objective of this study is to determine ventricular loading conditions during and after PulseCath®  iVAC 2L support, and assess its impact on specific load dependent humoral factors and cardiac enzymes. These specific patterns are so far unknown and will be compared with the validated FDA-cleared and CE marked Impella CP. Three cases with Impella CP will be performed in this study to obtain the exact same measurements for comparing purposes. For more information about this trial, please follow this link.

Marcelo B Bastos , Maarten P van Wiechen & Nicolas M Van Mieghem*, Department of Interventional Cardiology, Erasmus University Medical Center, Rotterdam, The Netherlands *Author for correspondence: Tel.: +31 010 703 5260; Fax: +31 010 436 9154; n.vanmieghem@erasmusmc.nl Please follow this link for the publication.

B. Bastos M. 1 , JJ. Schreuder 1 , J. Daemen 1 , CA. Den Uil 1,2 , NM. Van Mieghem 1 (1) Erasmus Medical Center, Interventional Cardiology, Rotterdam, Netherlands (2) Erasmus Medical Center, Department of Intensive Care Medicine, Rotterdam, Netherlands Click here to read the Poster ACURE 20.08.219

Alexander Samol,1 Blerim Luani,2 Sven Kaese,3 Marcus Wiemer3 1Johannes Wesling University Hospital, Department of Cardiology and Critical Care Medicine, Minden, Germany; 2 Ruhr University Bochum, Minden, Germany; 3 Johannes Wesling University Hospital Minden, Minden, Germany Read here the full Jacc Publication B319.full Jacc Publication Ivac vs Impella

Marcelo Barros Bastos, MD; Joost Daemen, MD, PhD; Nicolas M. ترتيب البوكر ivermectin 200 g/kg Van Mieghem*, MD, PhD Department of Cardiology, Erasmus Medical Center, Thoraxcentrum, Rotterdam, the Netherlands Click here for publication: 2018 Haemodynamic impact of a new pulsatile circulatory support in high risk coronary stenting

New publication at EuroIntervension 2019 Click here for Download article new-generation-mechanical-circulatory-support-during-high-risk-pci-a-cross-secti (1)

Head to head comparison of a pulsatile and a continuous flow left ventricular assist device in high-risk PCI setting – iVAC 2L vs. Impella Alexander Samol1, Stefanie Schmidt1, Blerim Luani1, Sven Kaese1, Melanie Zeyse1, Marcus Wiemer1 1Department of Cardiology and Critical Care Medicine, Johannes Wesling University Hospital, Minden, Germany Click to download study  EuroPCRposter Ivac Vs Impella

Immediate Effects of Pneumatic Left Ventricular Unloading in High-risk Percutaneous Coronary Revascularization. September 2018 – TCT publication  Bastos MB, Daemen J, den Uil C, Schreuder J, Van Mieghem NM Interventional Cardiology, Thoraxcentrum, ErasmusMC, Rotterdam, The Netherlands  For full article click here – Poster Patient 10 – 2018.09.10 sizedNVM

Effects of Pulsatile Left Ventricular Support on Mechanical Efficiency in Ischemic Cardiomyopathy – September 2018 – TCT Publication Bastos MB, Daemen J, den Uil C, Schreuder J, Van Mieghem NM Interventional Cardiology, Thoraxcentrum, ErasmusMC, Rotterdam, The Netherlands   For full article click here –    Poster – 2018.09.10 sizedNVM